首页> 外文期刊>Recent patents on drug delivery & formulation >Recent advances in the oral delivery of insulin
【24h】

Recent advances in the oral delivery of insulin

机译:口服胰岛素的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Insulin was discovered over 90 years ago. However oral insulin still remains a challenging and elusive goal. Extensive efforts are being made worldwide for developing noninvasive drug delivery systems, mainly via oral route as it is the most widely accepted means of administration. The main barriers faced in oral protein delivery are the enzymatic degradation and poor permeability across the intestinal wall. The approaches for developing an oral insulin delivery system mainly focus on overcoming these barriers. To overcome the gastro-intestinal barriers various types of formulations such as insulin conjugates, permeation enhancers, microanoparticles, liposomes etc. are investigated. In the recent years a number of advances have taken place in understanding the needs and workable mechanisms of improved oral peptide delivery systems. In this review the recent patents on oral insulin is focused. Emphasis is on the technologies based on permeation enhancers and nanoparticle based carrier systems.
机译:胰岛素是在90多年前发现的。然而,口服胰岛素仍然是一个具有挑战性和难以捉摸的目标。世界范围内正在广泛地开发无创药物递送系统,主要是通过口服途径,因为它是最广泛接受的给药方式。口服蛋白质递送面临的主要障碍是酶降解和肠壁通透性差。开发口服胰岛素递送系统的方法主要集中于克服这些障碍。为了克服胃肠道障碍,研究了各种类型的制剂,例如胰岛素缀合物,渗透促进剂,微米/纳米颗粒,脂质体等。近年来,在理解改进的口服肽递送系统的需求和可行机制方面已经取得了许多进展。在这篇综述中,重点介绍了有关口服胰岛素的最新专利。重点是基于渗透促进剂和基于纳米颗粒的载体系统的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号